Filings
| Filing | Date | Type | Filed with |
|---|
| 6-K · Report of a foreign issuer | Nov 18, 2026 | Current report | SEC |
|---|
| Results of Annual General Meeting | Nov 18, 2026 | Meeting outcome | ASX |
|---|
| CEO Address | Nov 17, 2026 | Annual report | ASX |
|---|
| 6-K · Report of a foreign issuer | Nov 10, 2026 | Current report | SEC |
|---|
| Immuron Engages LifeSci Capital | Nov 10, 2026 | Other filings | ASX |
|---|
| 6-K · Report of a foreign issuer | Oct 28, 2026 | Current report | SEC |
|---|
| Emerging Growth Conference Presentation | Oct 28, 2026 | Other filings | ASX |
|---|
| 6-K · Report of a foreign issuer | Oct 27, 2026 | Current report | SEC |
|---|
| Immuron Updates At-The-Market Funding Facility | Oct 26, 2026 | Financing | ASX |
|---|
| Immuron FY27 Sales Update | Oct 26, 2026 | Results | ASX |
|---|
| 6-K · Report of a foreign issuer | Oct 23, 2026 | Current report | SEC |
|---|
| 424B5 · Prospectus | Oct 23, 2026 | Offer document | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 21, 2026 | Current report | SEC |
|---|
| CEO to present at Emerging Growth Conference | Oct 21, 2026 | Notification letter | ASX |
|---|
| 6-K · Report of a foreign issuer | Oct 16, 2026 | Current report | SEC |
|---|
| Notice of Annual General Meeting and Proxy Form | Oct 15, 2026 | Meeting notice | ASX |
|---|
| 6-K · Report of a foreign issuer | Oct 13, 2026 | Current report | SEC |
|---|
| Travelan Phase 2 Study Results Published | Oct 12, 2026 | Results | ASX |
|---|
| Change in substantial holding | Sep 30, 2026 | Ownership change notice | ASX |
|---|
| 20-F · Annual report | Sep 24, 2026 | Annual report | SEC |
|---|
| 6-K · Report of a foreign issuer | Sep 24, 2026 | Current report | SEC |
|---|
| Appendix 4G and Corporate Governance Statement | Sep 24, 2026 | Other filings | ASX |
|---|
| Annual Report | Sep 24, 2026 | Annual report | ASX |
|---|
| 6-K · Report of a foreign issuer | Sep 21, 2026 | Current report | SEC |
|---|
| Presentation to Coffee Microcaps Conference | Sep 21, 2026 | Other filings | ASX |
|---|
| 6-K · Report of a foreign issuer | Sep 3, 2026 | Current report | SEC |
|---|
| PROIBS US Distribution Agreement | Sep 3, 2026 | Operations update | ASX |
|---|
| 6-K · Report of a foreign issuer | Aug 28, 2026 | Current report | SEC |
|---|
| FY26 Results Presentation | Aug 27, 2026 | Other filings | ASX |
|---|
| Appendix 4E Preliminary Final Report | Aug 27, 2026 | Results | ASX |
|---|
| 6-K · Report of a foreign issuer | Aug 18, 2026 | Current report | SEC |
|---|
| Emerging Growth Conference Presentation | Aug 18, 2026 | Other filings | ASX |
|---|
| 6-K · Report of a foreign issuer | Aug 12, 2026 | Current report | SEC |
|---|
| Emerging Growth Conference | Aug 12, 2026 | Meeting notice | ASX |
|---|
| 6-K · Report of a foreign issuer | Jul 27, 2026 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jul 20, 2026 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jul 20, 2026 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jul 15, 2026 | Current report | SEC |
|---|
| Immuron FY26 Sales Update | Jul 15, 2026 | Results | ASX |
|---|
| 6-K · Report of a foreign issuer | Jul 6, 2026 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jun 29, 2026 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jun 22, 2026 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jun 18, 2026 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | May 28, 2026 | Current report | SEC |
|---|
| 3 · Initial statement of ownership | May 14, 2026 | Insider trade | SEC |
|---|
| 3 · Initial statement of ownership | May 14, 2026 | Insider trade | SEC |
|---|
| 6-K · Report of a foreign issuer | May 7, 2026 | Current report | SEC |
|---|
| 3 · Initial statement of ownership | May 4, 2026 | Insider trade | SEC |
|---|
| 6-K · Report of a foreign issuer | Apr 30, 2026 | Current report | SEC |
|---|
| 3 · Initial statement of ownership | Apr 29, 2026 | Insider trade | SEC |
|---|
| 3 · Initial statement of ownership | Apr 29, 2026 | Insider trade | SEC |
|---|
| 3 · Initial statement of ownership | Apr 29, 2026 | Insider trade | SEC |
|---|
| 3 · Initial statement of ownership | Apr 29, 2026 | Insider trade | SEC |
|---|
| 3 · Initial statement of ownership | Apr 29, 2026 | Insider trade | SEC |
|---|
| 6-K · Report of a foreign issuer | Apr 16, 2026 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Apr 13, 2026 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Mar 5, 2026 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Feb 27, 2026 | Current report | SEC |
|---|
| Strategic Update and HY26 Results | Feb 25, 2026 | Other filings | ASX |
|---|
| Appendix 4D and Half Year Report | Feb 25, 2026 | Interim report | ASX |
|---|
| 6-K · Report of a foreign issuer | Feb 17, 2026 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Feb 12, 2026 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Feb 9, 2026 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jan 22, 2026 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jan 20, 2026 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jan 14, 2026 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jan 12, 2026 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Dec 16, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Dec 15, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Dec 12, 2025 | Current report | SEC |
|---|
| Uniformed Services University to Release Topline Data | Dec 9, 2025 | Operations update | ASX |
|---|
| 6-K · Report of a foreign issuer | Dec 9, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Dec 5, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Dec 4, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Dec 3, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Dec 3, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Nov 21, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Nov 12, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Nov 6, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Nov 6, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Nov 5, 2025 | Current report | SEC |
|---|
| IMM-529 IND approved by FDA | Nov 5, 2025 | Other filings | ASX |
|---|
| Clinical Trial Update | Oct 30, 2025 | Operations update | ASX |
|---|
| 6-K · Report of a foreign issuer | Oct 30, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 27, 2025 | Current report | SEC |
|---|
| Immuron launch PROIBS for IBS | Oct 23, 2025 | Operations update | ASX |
|---|
| 6-K · Report of a foreign issuer | Oct 23, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 22, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 20, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 20, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 20, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 17, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 14, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 10, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 7, 2025 | Current report | SEC |
|---|
| 424B5 · Prospectus | Oct 3, 2025 | Offer document | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 3, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 1, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Sep 30, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Sep 25, 2025 | Current report | SEC |
|---|
| 20-F · Annual report | Sep 25, 2025 | Annual report | SEC |
|---|
| 6-K · Report of a foreign issuer | Sep 16, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Sep 2, 2025 | Current report | SEC |
|---|
| FY25 Results Presentation | Aug 28, 2025 | Other filings | ASX |
|---|
| Appendix 4E Preliminary Final Report | Aug 28, 2025 | Results | ASX |
|---|
| 6-K · Report of a foreign issuer | Aug 26, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Aug 15, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Aug 13, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jul 21, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jul 18, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jul 17, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jul 17, 2025 | Current report | SEC |
|---|
| FY25 global sales exceed projection, up 49% on prior year | Jul 16, 2025 | Results | ASX |
|---|
| 6-K · Report of a foreign issuer | Jun 4, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | May 30, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Apr 11, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Apr 10, 2025 | Current report | SEC |
|---|
| Immuron Travelan highest sales in history | Apr 10, 2025 | Results | ASX |
|---|
| 6-K · Report of a foreign issuer | Mar 7, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Mar 5, 2025 | Current report | SEC |
|---|
| IMC and Calmino to treat Irritable Bowel Syndrome (IBS) | Mar 4, 2025 | Other filings | ASX |
|---|
| 6-K · Report of a foreign issuer | Feb 28, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Feb 18, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jan 17, 2025 | Current report | SEC |
|---|
| Immuron Travelan continued strong sales growth | Jan 16, 2025 | Results | ASX |
|---|
| 6-K · Report of a foreign issuer | Jan 15, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jan 14, 2025 | Current report | SEC |
|---|
| Immuron Announces Travelan Clinical Trial Update | Jan 14, 2025 | Operations update | ASX |
|---|
| 6-K · Report of a foreign issuer | Jan 10, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jan 8, 2025 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Dec 10, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Nov 22, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Nov 18, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Nov 14, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 29, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 18, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 16, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 15, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 8, 2024 | Current report | SEC |
|---|
| NMRC Reports Results for Campylobacter Clinical Study | Oct 4, 2024 | Results | ASX |
|---|
| 6-K · Report of a foreign issuer | Oct 4, 2024 | Current report | SEC |
|---|
| Trading Halt | Oct 2, 2024 | Trading halt or suspension | ASX |
|---|
| 20-F · Annual report | Oct 1, 2024 | Annual report | SEC |
|---|
| 6-K · Report of a foreign issuer | Sep 26, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Sep 9, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Sep 5, 2024 | Current report | SEC |
|---|
| Immuron Plans Phase 2 Trial for IMM-529 following FDA review | Sep 5, 2024 | Other filings | ASX |
|---|
| Appendix 4E and Preliminary Final Report | Aug 30, 2024 | Results | ASX |
|---|
| 6-K · Report of a foreign issuer | Aug 21, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Aug 16, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Aug 8, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Aug 7, 2024 | Current report | SEC |
|---|
| EFFECT · Notice that a registration is effective | Jul 22, 2024 | Other filings | SEC |
|---|
| 6-K · Report of a foreign issuer | Jul 18, 2024 | Current report | SEC |
|---|
| CORRESP · Letter to the SEC | Jul 18, 2024 | Other filings | SEC |
|---|
| 6-K · Report of a foreign issuer | Jul 15, 2024 | Current report | SEC |
|---|
| Immuron Travelan record sales globally, Australia and USA | Jul 14, 2024 | Results | ASX |
|---|
| 6-K · Report of a foreign issuer | Jul 9, 2024 | Current report | SEC |
|---|
| UPLOAD · Letter from the SEC | Jul 8, 2024 | Other filings | SEC |
|---|
| 6-K · Report of a foreign issuer | Jul 5, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jul 3, 2024 | Current report | SEC |
|---|
| F-3 · Registration statement | Jul 2, 2024 | Offer document | SEC |
|---|
| 6-K · Report of a foreign issuer | Jul 2, 2024 | Current report | SEC |
|---|
| IMM-529 pre-IND FDA filing | Jul 1, 2024 | Other filings | ASX |
|---|
| 6-K · Report of a foreign issuer | Jun 5, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | May 31, 2024 | Current report | SEC |
|---|
| 6-K/A · Report of a foreign issuer, amended | May 24, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | May 3, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Apr 23, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Apr 15, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Apr 10, 2024 | Current report | SEC |
|---|
| Immuron Travelan sales continued strong growth | Apr 9, 2024 | Results | ASX |
|---|
| 6-K · Report of a foreign issuer | Mar 14, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Mar 7, 2024 | Current report | SEC |
|---|
| Travelan to progress to Phase 3 Clinical Trials in the US | Mar 6, 2024 | Operations update | ASX |
|---|
| 6-K · Report of a foreign issuer | Mar 4, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Feb 28, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Feb 21, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Feb 13, 2024 | Current report | SEC |
|---|
| Immuron achieves record Travelan sales | Feb 12, 2024 | Results | ASX |
|---|
| 6-K · Report of a foreign issuer | Feb 8, 2024 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Jan 16, 2024 | Current report | SEC |
|---|
| Immuron achieves record half yearly Travelan sales | Jan 15, 2024 | Results | ASX |
|---|
| 6-K · Report of a foreign issuer | Dec 22, 2023 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Dec 4, 2023 | Current report | SEC |
|---|
| First Patients Enrolled in Campylobacter Clinical Study | Dec 4, 2023 | Operations update | ASX |
|---|
| 6-K · Report of a foreign issuer | Nov 28, 2023 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Nov 22, 2023 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Nov 21, 2023 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Nov 13, 2023 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 30, 2023 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 23, 2023 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 18, 2023 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Oct 11, 2023 | Current report | SEC |
|---|
| Immuron achieves record quarterly Travelan sales | Oct 11, 2023 | Results | ASX |
|---|
| 6-K · Report of a foreign issuer | Oct 3, 2023 | Current report | SEC |
|---|
| 6-K · Report of a foreign issuer | Sep 28, 2023 | Current report | SEC |
|---|
| 20-F · Annual report | Sep 28, 2023 | Annual report | SEC |
|---|
| 6-K · Report of a foreign issuer | Sep 13, 2023 | Current report | SEC |
|---|
| Immuron achieves record monthly Travelan sales | Sep 13, 2023 | Results | ASX |
|---|
This page holds 200 of 604 filings.
All of its filings on SEC EDGAR